Market›Health Care›Pharmaceuticals›Pharmaceuticals
RVL PHARMACEUTICALS

RVLPQ

$0.00Apr 28, 2021 – Apr 27, 2026
Health CarePharmaceuticals$0M
MVM
+$0.0M

Every news event mapped to its market reaction — 33 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2023-08-16-55.7%newsSeeking AlphaRVL Pharmaceuticals shares fall after pricing $5M stock offering
2023-10-25+53.7%newsTradingViewRVLPQ Stock Price and Chart — OTC:RVLPQ - TradingView
2023-10-12-52.5%newsSeeking AlphaRVL Pharma drops as subsidiaries seek bankruptcy
2022-10-18-19.6%earningsSeeking AlphaRVL Pharmaceuticals sees Q3 net sales of UPNEEQ for eye treatment about $10M
2023-03-20-19.0%earningsSeeking AlphaRVL Pharmaceuticals (RVLP) Q4 2022 Earnings Call Transcript
2023-03-20-19.0%earningsSeeking AlphaRVL Pharmaceuticals plc GAAP EPS of -$0.18 misses by $0.01, revenue of $9.81M misses by $2.72M
2022-09-22-17.4%newsSeeking AlphaRVL Pharmaceuticals: Chapter 2 - A Developing Quandary
2022-09-13+13.9%newsSeeking AlphaRVL Pharmaceuticals (RVLP) presents at H.C. Wainwright 24th Annual Global Investment Conference - Slideshow
2023-01-09+13.8%earningsSeeking AlphaRVL Pharmaceuticals stock soars after sees Q4 net sales of UPNEEQ about $12.1M, up 21% Q/Q
2022-12-30+13.4%newsSeeking AlphaRVL Pharmaceuticals: A First 'Look'
2022-11-10-10.5%earningsSeeking AlphaRVL Pharmaceuticals plc GAAP EPS of -$0.16 in-line, revenue of $10.02M in-line
2023-08-14-7.7%earningsSeeking AlphaRVL Pharmaceuticals plc (RVLP) Q2 2023 Earnings Call Transcript
2023-08-14-7.7%earningsSeeking AlphaRVL Pharmaceuticals plc 2023 Q2 - Results - Earnings Call Presentation
2023-08-14-7.7%earningsSeeking AlphaRVL Pharmaceuticals plc GAAP EPS of -$0.24 misses by $0.12, revenue of $8.26M misses by $1.99M
2022-08-30+7.0%newsSeeking AlphaRVL Pharma in pact with Revision Skincare to broaden access to products
2022-07-07+6.3%newsSeeking AlphaRVL Pharma posts preliminary 42% sales growth for eye treatment
2023-05-11+6.1%earningsSeeking AlphaRVL Pharmaceuticals plc (RVLP) Q1 2023 Earnings Call Transcript
2023-05-11+6.1%earningsSeeking AlphaRVL Pharmaceuticals plc GAAP EPS of -$0.12 in-line, revenue of $8.83M misses by $0.37M
2022-08-11+3.9%earningsSeeking AlphaRVL Pharmaceuticals plc (RVLP) CEO Brian Markison on Q2 2022 Results - Earnings Call Transcript
2022-08-11+3.9%earningsSeeking AlphaGAAP EPS of -$0.14 beats by $0.07, revenue of $8.45M misses by $0.07M
2022-06-11-3.4%newsSeeking AlphaRVL Pharmaceuticals (RVLP) Investor Presentation - Slideshow
2022-11-11+3.4%earningsSeeking AlphaRVL Pharmaceuticals plc (RVLP) Q3 2022 Earnings Call Transcript
2022-11-25-3.2%newsGuruFocusFred G Weiss Net Worth (2026) - GuruFocus
2022-11-28-3.0%newsGuruFocusCarlos Alberto Sielecki Net Worth (2026) - GuruFocus
2023-07-05-2.9%newsSeeking AlphaRVL Pharma spikes on strategic review
2022-03-30-1.3%earningsSeeking AlphaRVL Pharmaceuticals plc (RVLP) CEO Brian Markison on Q4 2021 Results - Earnings Call Transcript
2022-03-30-1.3%earningsSeeking Alphareports Q4 results
2022-03-30-1.3%newsSeeking AlphaRVL Pharmaceuticals: A Makeover For An Ugly Duckling
2022-06-15+1.1%newsSeeking AlphaRVL Pharmaceuticals: Chapter 1 Gives A Mixed Picture
2022-04-06+1.1%earningsSeeking AlphaRVL Pharmaceuticals stock rises on preliminary Q1 sales of eye drug Upneeq
2022-05-12+0.6%earningsSeeking AlphaRVL Pharmaceuticals plc (RVLP) CEO Brian Markison on Q1 2022 Results - Earnings Call Transcript
2022-05-12+0.6%earningsSeeking AlphaGAAP EPS of -$0.08 beats by $0.13, revenue of $21.4M beats by $14.6M
2022-01-19+0.3%earningsSeeking AlphaOsmotica renames as RVL Pharmaceuticals; provides Q4 net sales guidance
tickerdossier.comtickerdossier.substack.com